Chapters
Skip to …
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Alendronic acid 70mg effervescent tablets (Binosto®) |
Third line option in individuals who have not tolerated first line alendronate tablets and second line risedronate tablets and in whom a bone-sparing agent is still considered clinically necessary |
|
|
|
Alendronic acid tablets | ||
|
Calcitonin injection (Salmon) | ||
|
|
Calcitonin nasal spray (Salmon) | ||
|
|
Cetrorelix injection | ||
|
Denosumab injection (Prolia®) |
ESCA |
|
|
|
Denosumab injection (Xgeva®) | ||
|
|
Disodium etidronate (Didronel®) | ||
|
|
Disodium etidronate tablets | ||
|
|
Disodium pamidronate injection | ||
|
|
Ibandronic acid injection | ||
|
|
Ibandronic acid tablet |
ESCA |
|
|
|
Parathyroid hormone injection | ||
|
|
Risendronate tablets | ||
|
|
Romosozumab (Evenity®) | ||
|
|
Sodium clodronate capsules |
ESCA |
|
|
|
Teriparatide injection | ||
|
|
Zoledronic acid injection |
